Prevalence of nephropathy in type I diabetes;Prevalencia de nefropatía en la diabetes mellitus tipo I

Medicina Clinica

Volumn 110, Issue 1, 1998, Pages 6-10

  Esmatjes, Enric ^a,f   Castell, Conxa ^f   Goday, Albert ^b   Montanya, Eduard ^c   Pou, Josep Ma ^d   Salinas, Isabel ^e   Simó, Rafael ^f   González, Maria Teresa ^f   Tresserras, Ricard ^f   Lloveras, Gonçal ^f  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DIABETIC NEPHROPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PREVALENCE; RISK FACTOR; SPAIN; STATISTICAL MODEL;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREVALENCE; RISK FACTORS; SPAIN;

EID: 0032539280     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetes with diabetes onset before the age of thirty-one. Diabetologia 1978; 14: 363-370.
2. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985; 28: 590-596.
3. Health Care Financing Administration, Bureau of Data Management and Strategy. Data from the program management and medical information systems, 1979-1984 and census population estimates. Series P-25, n.o 965.
4. Generalitat de Catalunya. Servei Català de la Salut. Registre de malalts renais de Catalunya. Informe estadistic 1994. Barcelona: Departament de Sanitat i Seguretat Social, 1995.
5. Mogensen CE, Schmitz O, The diabetic kidney: from hyperfiltration and microalbuminuria to end-state renal failure. Med Clin North Am 1988; 72: 1.465-1.492.
6. Mathiensen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent). Diabetologia 1984; 26: 406-410.
7. Parving HH, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes Br Med J 1988; 296: 156-160.
8. Mangili R, Deferrari G, Di Mario U, Giampietro O, Navalesi R, Nosadini R et al, for the Italian Microalbuminuria Study Group. Arterial hypertension and microalbuminuria in IDDM: the italian microalbuminuria Study. Diabetologia 1994; 37: 1.015-1.024.
9. Eggers PW, Connerton P, McMullan M. The Medicare experience with end-stage renal disease. Health Care Financin Rev 1984; 5: 69-88.
10. Anderson AR, Christiansen JS, Andersen JK, Kreiner S, Deckter T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiologic study. Diabetologia 1983; 25: 496-501.
11. Consensus Statement. Report and recommendations of the San Antonio Conference on Diabetes Neuropathy. Diabetes 1988; 37: 1.000-1.004.
12. Jury DR, Mikkelsen DJ, Dunn PJ. Prozone effect and the immunoturbidimetric measurement of albumin in urine. Clin Chem 1990; 36: 1.518.
13. Marre M, Claudel JP, Ciret P, Luis N, Suárez L, Passa P. Laser immunonephelometry for routine quanlification of urinary albumin excretion. Clin Chem 1987; 33: 209-214.
14. Altman DG. Practical statistics for medical research. Londres: Chapman and Hall, 1991.
15. Rice WR. Analyzing tables of statistical tests. Evolution 1979; 43: 223-225.
16. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
17. Armitage P, Neny G. Statistical methods in medical research. Oxford: Blackwell, 1987.
18. Zeller K, Whittaker E, Sullivan L, Raskin P. Effect of restricting dietary protein on progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 78-84.
19. Raine AEG. Epidemiology, development treatment of end-stage renal failure in type 2 (non insulin-dependent) diabetic patients in Europe. Diabetologia 1993; 36: 1.099-1.104.
20. Microalbuminuria Collaborative Study Group. Microalbuminuria in type I diabetic patients. Diabetes Care 1992; 15: 495-501.
21. Krolewski AS, Warram JH, Rand LI, Kahn CR. Epidemiologic approach to the etiology of type I diabetes and its complications. N Engl J Med 1987; 317: 1.390-1.398.
22. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685-689.
23. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function and decrease in albumin by captopril in insulin dependent diabetics with nephropathy. Br Med J 1987; 294: 1.443-1.447.
24. Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving HH et al. Diabetic Renal Disease Recommendations. Am J Kidney Dis 1995; 25: 107-112.
25. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986,
26. Krolewski AS, Laffel L, Krolewski M, Quinn M, Warram JH. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995; 332: 1.251-1255.
27. Gatling W, Mulee MA, Knight C, Hill RD. Microalbuminuria in diabetes: relationships between urinary albumin excretion and diabetes-related variables. Diabetic Medicine 1988; 5: 348-351.
28. Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion, Diabetologia 1988; 31: 142-145.
29. Coonrod BA, Ellis D, Becker DJ, Bunker CH, Kelsey SF, Lloyd CE et al. Predictors of microalbuminuria in individuals with IDDM. Diabetes Care 1993; 16: 1.376-1.383.
30. Ravid M, Neumann L, Lishner M. Plasma lipids and the progresion of nephropathy in diabetes mellitus type II: effect of ACE inhibitors. Kidney Int 1995; 47: 907-910.
31. Marre M, Girault A, Vasmant D Prevalence de la microalbuminurie chez les diabetiques de type 2 français suivis par leur medicin general. Diabete & Metabolisme 1995; 21: 1.099-1.104.
32. Esmatjes E, Castell C, González T, Tresseras R, Lloveras G and The Catalan Diabetic Nephropathy Study Group. Epidemiology of renal involvement in type II diabetics (NIDDM) in Catalonia. Diabetes Res Clin Prac 1996; 32: 157-163.
33. West KM, Erdreich LS, Stoker JA. Absence of a relationship between smoking and diabetic microangiopathy. Diabetes Care 1980; 3: 250-252.
34. Olivarus NF, Andreasen AH, Keiding N, Mogensen CE. Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data form the population study. Diabetes care in general practice, Denmark. Diabetologia 1993; 36: 1.007-1.006.
35. Esmatjes E, Gutiérrez A, Goday A, Novials A, Ricart MJ, Gonzalez MT et al. Historia natural de la nefropatía diabética en la diabetes mellitus tipo I. Med Clin (Barc) 1988; 90: 47-51.